Suppr超能文献

胡萝卜过敏的组分解析体外诊断:使用重组胡萝卜过敏原能否提高诊断程序的可靠性?

Component-resolved in vitro diagnosis in carrot allergy: does the use of recombinant carrot allergens improve the reliability of the diagnostic procedure?

作者信息

Ballmer-Weber B K, Wangorsch A, Bohle B, Kaul S, Kündig T, Fötisch K, van Ree R, Vieths S

机构信息

Allergy Unit, Department of Dermatology, University Hospital, Zürich, Switzerland.

出版信息

Clin Exp Allergy. 2005 Jul;35(7):970-8. doi: 10.1111/j.1365-2222.2005.02294.x.

Abstract

BACKGROUND

In Europe, pollen-related food allergy is the most frequent form of food allergy in adults. Reliability of current diagnostic procedures, however, is poor and therapeutic options are not available.

OBJECTIVES

In the present study, we created a panel of recombinant allergens from carrot and evaluated its potential in component-resolved in vitro diagnosis of carrot allergy.

METHODS

Recombinant (r) Dau c 1.0104, Dau c 1.0201 and Dau c 4 were cloned by a polymerase chain reaction strategy, expressed in Escherichia coli and purified. Carrot lipid transfer protein (LTP) was expressed in the yeast Pichia pastoris. Sera from 40 carrot-allergic patients were investigated. Twenty-one birch pollen-allergic subjects with negative open provocation to carrot and 20 non-allergic subjects were included as controls. IgE binding to recombinant allergens as well as to cross-reactive carbohydrate determinants (CCD) was measured by ELISA. Cross-reactivity between Dau c 1 isoforms and Bet v 1 was assayed by ELISA inhibition. Biological activity of the recombinant carrot allergens was assessed by histamine release assay and peripheral blood mononuclear cells stimulation.

RESULTS

Ninety-eight percent of the carrot-allergic patients were positive to at least one recombinant allergen; 98% reacted to rDau c 1.0104, 65% to rDau c 1.0201, 38% to rDau c 4 and 20% had IgE against CCD. Specificity using the recombinant allergens was high when compared with non-allergic controls, but low compared with birch-sensitized subjects without carrot allergy. Sensitization to Dau c 1.0201, however, proved to be highly specific for clinically relevant sensitization. Inhibition assays indicated the absence of LTP in carrot root extract, and epitope diversity between Dau c 1.0104, Dau c 1.0201 and Bet v 1.

CONCLUSIONS

Our panel of recombinant allergens from carrot can provide a standardized tool for in vitro diagnosis of carrot allergy, and for epitope studies.

摘要

背景

在欧洲,花粉相关的食物过敏是成人中最常见的食物过敏形式。然而,目前诊断程序的可靠性较差,且缺乏治疗选择。

目的

在本研究中,我们构建了一组来自胡萝卜的重组变应原,并评估其在胡萝卜过敏的组分解析体外诊断中的潜力。

方法

通过聚合酶链反应策略克隆重组(r)Dau c 1.0104、Dau c 1.0201和Dau c 4,在大肠杆菌中表达并纯化。胡萝卜脂质转移蛋白(LTP)在毕赤酵母中表达。研究了40例胡萝卜过敏患者的血清。纳入21例对胡萝卜开放激发试验阴性的桦树花粉过敏受试者和20例非过敏受试者作为对照。通过酶联免疫吸附测定(ELISA)检测IgE与重组变应原以及与交叉反应性碳水化合物决定簇(CCD)的结合。通过ELISA抑制试验检测Dau c 1亚型与Bet v 1之间的交叉反应性。通过组胺释放试验和外周血单核细胞刺激评估重组胡萝卜变应原的生物活性。

结果

98%的胡萝卜过敏患者对至少一种重组变应原呈阳性反应;98%对rDau c 1.0104有反应,65%对rDau c 1.0201有反应,38%对rDau c 4有反应,20%有针对CCD的IgE。与非过敏对照相比,使用重组变应原的特异性较高,但与无胡萝卜过敏的桦树致敏受试者相比则较低。然而,对Dau c 1.0201的致敏被证明对临床相关致敏具有高度特异性。抑制试验表明胡萝卜根提取物中不存在LTP,且Dau c 1.0104、Dau c 1.0201和Bet v 1之间存在表位多样性。

结论

我们的一组来自胡萝卜的重组变应原可为胡萝卜过敏的体外诊断和表位研究提供标准化工具。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验